Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease

被引:61
作者
Weimer, LH
Podwall, D
机构
[1] Columbia Univ Coll Phys & Surg, Dept Neurol, Inst Neurol, New York, NY 10032 USA
[2] Albert Einstein Coll Med, Neurol Associates Long Isl, New York, NY 10021 USA
关键词
toxic neuropathy; vincristine; chemotherapy; nucleoside analogs; hereditary neuropathy; drug-induced neuropathy;
D O I
10.1016/j.jns.2005.11.014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Toxin or medication-induced worsening of preexisting peripheral neuropathy is a generally accepted but not well-studied phenomenon in humans. Drug-induced exacerbation of Charcot Marie Tooth disease (CMT) neuropathy is a common concern; a list of potential drugs to avoid is maintained by the CMT Association but with limited direct evidence or advice on relative risk. An extensive literature search for reported cases of drug effects in CMT patients found the vast majority concerned excessive vincristine toxicity in patients with undiagnosed demyelinating forms of CMT, many after I or 2 doses. The CMT North American database was also queried for all drug-related effects. All but one drug cited as worsening neuropathy was present on a compiled inclusive list. These results and other available evidence were used to develop a revised risk stratified list for CMT patients and clinicians to consult prior to discussing risk to benefit ratios and making treatment decisions. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 36 条
[21]   Peripheral neuropathy in patients with HIV infection: consider dual pathology [J].
Miller, RF ;
Bunting, S ;
Sadiq, ST ;
Manji, H .
SEXUALLY TRANSMITTED INFECTIONS, 2002, 78 (06) :462-463
[22]  
Moudgil SS, 2000, ANN PHARMACOTHER, V34, P1136
[23]   Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity [J].
Naumann, R ;
Mohm, J ;
Reuner, U ;
Kroschinsky, F ;
Rautenstrauss, B ;
Ehninger, G .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (02) :323-325
[24]  
Neumann Y, 1996, MED PEDIATR ONCOL, V26, P280
[25]  
Olek Michael J., 1999, Journal of the American Osteopathic Association, V99, P165
[26]   Charcot-Marie-Tooth disease and vincristine [J].
Orejana-García, AM ;
Pascual-Huerta, J ;
Pérez-Melero, A .
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2003, 93 (03) :229-233
[27]   Recent advances in drug-induced neuropathies [J].
Peltier, AC ;
Russell, JW .
CURRENT OPINION IN NEUROLOGY, 2002, 15 (05) :633-638
[28]   Medication and toxin-induced peripheral neuropathy [J].
Pratt, RW ;
Weimer, LH .
SEMINARS IN NEUROLOGY, 2005, 25 (02) :204-216
[29]   MITOCHONDRIAL RIBOSOMAL-RNA MUTATION ASSOCIATED WITH BOTH ANTIBIOTIC-INDUCED AND NON-SYNDROMIC DEAFNESS [J].
PREZANT, TR ;
AGAPIAN, JV ;
BOHLMAN, MC ;
BU, XD ;
OZTAS, S ;
QIU, WQ ;
ARNOS, KS ;
CORTOPASSI, GA ;
JABER, L ;
ROTTER, JI ;
SHOHAT, M ;
FISCHELGHODSIAN, N .
NATURE GENETICS, 1993, 4 (03) :289-294
[30]   Brief report - Vincristine neuropathy: Neurophysiological and genetic studies in a case of Wilms tumor [J].
Schiavetti, A ;
Frascarelli, M ;
Uccini, S ;
Novelli, A .
PEDIATRIC BLOOD & CANCER, 2004, 43 (05) :606-609